Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2025)
Sanara MedTech's Income from Non-Controlling Interests history spans 7 years, with the latest figure at -$244.0 for Q4 2025.
- For Q4 2025, Income from Non-Controlling Interests rose 99.85% year-over-year to -$244.0; the TTM value through Dec 2025 reached -$5441.0, up 97.83%, while the annual FY2025 figure was -$5441.0, 97.8% up from the prior year.
- Income from Non-Controlling Interests reached -$244.0 in Q4 2025 per SMTI's latest filing, up from -$955.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $242000.0 in Q4 2022 to a low of -$165244.0 in Q4 2024.
- Average Income from Non-Controlling Interests over 5 years is -$5972.8, with a median of -$25267.0 recorded in 2023.
- The largest YoY upside for Income from Non-Controlling Interests was 5032.18% in 2021 against a maximum downside of 809.07% in 2021.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$8277.0 in 2021, then soared by 3023.76% to $242000.0 in 2022, then crashed by 110.43% to -$25250.0 in 2023, then crashed by 554.43% to -$165244.0 in 2024, then surged by 99.85% to -$244.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Income from Non-Controlling Interests are -$244.0 (Q4 2025), -$955.0 (Q3 2025), and -$4036.0 (Q2 2025).